483
Apotex Inc.Apotex Inc. – FDA 483, Sep 14, 2022
Record Details
During an inspection of Apotex Inc. in Richmond Hill, FDA investigators observed that the firm's procedures for preventing microbiological contamination of sterile drug products were not adequately established. Specifically, the firm failed to properly define and document responses to critical interventions on its sterile filling line, which could compromise product sterility.
View Company Profile
ID · 30390ae8-4b97-4980-b67e-c38edef4e751
Other documents for Apotex Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.